Celltrion, Inc. (KRX:068270)
 176,900
 +1,800 (1.03%)
  Last updated: Oct 31, 2025, 10:19 AM KST
Celltrion Market Cap
Celltrion has a market cap or net worth of 38.62 trillion as of October 31, 2025. Its market cap has decreased by -4.23% in one year.
Market Cap 
 38.62T
Enterprise Value 
 40.49T
Revenue 
 3.75T
Ranking 
 n/a
PE Ratio 
 79.71
Stock Price 
176,900.00
Market Cap Chart
Since August 20, 2008, Celltrion's market cap has increased from 103.80B to 38.62T, an increase of 37,103.06%. That is a compound annual growth rate of 41.06%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 30, 2025 | 38.57T | -4.44% | 
| Dec 30, 2024 | 40.37T | 44.32% | 
| Dec 28, 2023 | 27.97T | 21.61% | 
| Dec 29, 2022 | 23.00T | -16.64% | 
| Dec 30, 2021 | 27.59T | -43.68% | 
| Dec 30, 2020 | 48.99T | 102.64% | 
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro | 
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro | 
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro | 
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro | 
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro | 
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Samsung Biologics | 86.90T | 
| ALTEOGEN | 25.24T | 
| SK Biopharmaceuticals | 8.88T | 
| Yuhan | 8.68T | 
| HLB Co., Ltd. | 6.30T | 
| Peptron | 6.13T | 
| PharmaResearch | 5.36T | 
| LigaChem Biosciences | 5.15T |